Displaying 1–17 of 17 results for Patheon

Sort By Relevance Sort By Date

Thermo Fisher Scientific Closes $7.2B Patheon Deal

(News)

Thermo Fisher officially acquired Patheon for $7.2 billion, entering the CDMO arena serving the pharmaceutical and biotechnology sectors

Thermo Fisher Buys Patheon for $5.2B, Enters CDMO Arena

(News)

Patheon provides entry into the high-growth CDMO market and expands Thermo Fisher's biopharma services

Patheon Acquires Roche API Manufacturing Site

(News)

Patheon Acquires Roche API Manufacturing Site. A major supply agreement with Roche accompanies the acquisition of the Florence, South Carolina, site.

CPhI North America Debuts in May 2017

(News)

Perrigo Purchases Patheon's Mexican Operations

(News)

The acquisition broadens the company's presence, product portfolio and customer network in Mexico

Newly-Formed DPx Holdings Buys Gallus BioPharmaceuticals CMO

(News)

DPx Holdings B.V, the result of a $2.65 billion transaction between JLL Partners and Royal DSM finalized in March, has completed the transaction to acquire Gallus BioPharmaceuticals, LLC, a leading St. Louis-based contract manufacturing company specializing in biologics.

ISPE Panel Names 2014 Facility of the Year Awards

(News)

Winning projects for 2014 were selected from 27 well-qualified entries

Completed Patheon and DSM Merger Forms New Powerhouse CMO

(News)

$2.65 billion transaction combines the capabilities and expertise of Patheon and DSM Pharmaceutical Products to create industry powerhouse

QbD Included in DCAT Week '14 Lineup

(News)

DCAT Week '14, held March 10-14 in NYC, will address quality by design in a session titled, Quality by Design: Client, Contractor, and Regulatory Perspectives with Case Studies.

WellSpring Pharma Services Expands Business Development Team

(News)

WellSpring appoints Lonnie Barish, MBA, as executive director of business development, and David Watt as technical director, pharma services

DSM Biologics and Australian Plant Included in Patheon Merger

(News)

Royal DSM has confirmed that its biologics manufacturing operations and new Australian facility will be part of the business merged with Patheon in its agreement with JLL.

Royal DSM to Acquire Patheon and Create New, Global CDMO

(News)

The new company anticipates 2014 sales of about $2 billion

Patheon Enters into Agreement to Buy Banner Pharmacaps

(News)

Patheon acquires Banner Pharmacaps to build scale, expand capacity and broaden footprint in emerging markets

News: Global Pharmaceutical Contract Manufacturing Market to Reach US$40.7 ...

(News)

The global market for pharmaceutical contract manufacturing witnessed robust growth in recent years, and the future continues to hold tremendous prospects for the industry.

Contract Drug Developer Patheon Lets CEO Go, Seeks New Leadership

(News)

Contract drug developer Patheon said Wednesday it has let president and chief executive Wesley Wheeler go. Company chairman Ramsey Frank said Patheon has reached a stage where new leadership is required to realize its full potential. Peter Bigelow, president of Patheon's North American ...

Patheon Signs Deals with Sanofi-Aventis

(News)

Two five-year manufacturing agreements extend the partnership between the two companies.

Sort By Relevance Sort By Date